Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema

International Journal of COPD

Volumn 7, Issue , 2012, Pages 397-405

  Herth, Felix J F ^a   Ernst, Armin ^b   Baker, Kimberly M ^c   Egan, Jim J ^d   Gotfried, Mark H ^e   Hopkins, Peter ^f   Stanzel, Franz ^g   Valipour, Arschang ^h   Wagner, Manfred ⁱ   Witt, Christian ^j   Kesten, Steven ^k   Snell, Gregory ^l  

^a Pneumology and Critical Care Medicine   (Germany)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^e Pulmonary Associates   (United States)

^f THE PRINCE CHARLES HOSPITAL   (Australia)

^g Zentrum fur Pneumologie   (Germany)

^h OTTO WAGNER HOSPITAL   (Austria)

ⁱ KLINIKUM NÜRNBERG   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k Uptake Medical Corp   (United States)

^l ALFRED HOSPITAL   (Australia)

more..

Author keywords

Bronchoscopy; Emphysema; Lung volume reduction; Thermal energy

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBON MONOXIDE; STEROID; THEOPHYLLINE DERIVATIVE; TIOTROPIUM BROMIDE;

6 MINUTE WALK DISTANCE; ABLATION THERAPY; ADULT; AGED; ARTICLE; ASPERGILLOSIS; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DIABETES MELLITUS; DYSPNEA; ENDOSCOPIC SURGERY; ENDOSCOPIC THERMAL VAPOR ABLATION; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC HETEROGENEITY; HEART FAILURE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG RESECTION; LUNG VOLUME; MALE; MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PLETHYSMOGRAPHY; QUALITY OF LIFE; QUESTIONNAIRE; RESIDUAL VOLUME; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; ST GEORGE RESPIRATORY QUESTIONNAIRE; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; TOTAL LUNG CAPACITY; AUSTRALIA; BODY PLETHYSMOGRAPHY; BRONCHOSCOPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; EUROPE; EXERCISE TEST; EXERCISE TOLERANCE; LUNG; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; UNITED STATES; WALKING;

ABLATION TECHNIQUES; AGED; AUSTRALIA; BRONCHOSCOPY; EUROPE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY, WHOLE BODY; PNEUMONECTOMY; PULMONARY DIFFUSING CAPACITY; PULMONARY EMPHYSEMA; QUESTIONNAIRES; RECOVERY OF FUNCTION; RESIDUAL VOLUME; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; UNITED STATES; WALKING;

EID: 84863668380     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S31082     Document Type: Article

References (27)

1. Brantigan OC, Mueller E. Surgical treatment of pulmonary emphysema. Am Surg. 1957;23(9):789-804.
2. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1995;109(1):106-116.
3. The National Emphysema Treatment Trial Research Group. Rationale and design of the National Emphysema Treatment Trial: A prospective randomized trial to lung volume reduction surgery. Chest. 1999;116(6):1750-1761.
4. The National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severed emphysema. N Engl J Med. 2003;348(21): 2059-2073.
5. Naunheim KS, Wood DE, Mohsenifar Z, et al. National Emphysema Treatment Trial Research Group. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg. 2006;82:431-443.
6. Criner GJ, Cordova F, Sterberg AL, Martinez FJ. The NETT: Part II - lessons learned about lung volume reduction surgery. Am J Resp Crit Care Med. 2011;184(8):881-893.
7. Snell GI, Holsworth L, Borrill ZL, et al. The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest. 2003;124(3):1073-1080.
8. Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduc-tion with valve implants in patients with severe emphysema. Lancet. 2003;361(9361):931-933.
9. Hopkinson NS, Toma TP, Hansell DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med. 2005;171(5):453-460.
10. Venuta F, de Giacomo T, Rendina EA, et al. Bronchoscopic lung-volume reduction with one-way valves in patients with heterogeneous emphysema. Ann Thorac Surg. 2005;79(2):411-416.
11. Wan IY, Toma TP, Geddes DM, et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest. 2006;129(3):518-526.
12. Sciurba FC, Ernst A, Herth FJF, et al. A randomized study of endobron-chial valves for advanced emphysema. N Eng J Med. 2010;363(13): 1233-1244.
13. Herth FJF, Gompelmann D, Stanzel F, et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal®). Respiration. 2011;82(1):36-45.
14. Springmeyer S, Bolliger CT, Waddell TK, Gonzalez X, Wood DE. Treatment of heterogeneous emphysema using the Spiration IBV valves. Thorac Surg Clin. 2009;19:247-253.
15. Emery MJ, Eveland RL, Eveland KB, Couetil LL, Hildebrandt J, Swenson ER. Lung volume reduction by bronchoscopic administration of steam. Am J Respir Crit Care Med. 2010;182(10):1282-1291.
16. Snell GI, Hopkins P, Westall G, Holsworth L, Carle A, Williams TJ. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg. 2009;88(6):1993-1998.
17. Snell G, Herth FJ, Hopkins P, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J. 2012;39(6):1326-1333.
18. ATS statement: guidelines for the six-minute walk test. Am J Resp Crit Care Med. 2002;166(1):111-117.
19. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6): 1321-1327.
20. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586.
21. Celli B, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-1012.
22. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Executive summary. December 2011 Update. Global Initiative for Chronic Obstructive Lung Disease. Available from: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=989. Accessed February 2, 2011.
23. The World Health Report 2000. Statistical Annex. Geneva: World Health Organization; 2000. Available from: http://www.who.int/whr/2000/en/whr00_annex_en.pdf. Accessed February 2, 2011.
24. Tashkin DP, Celli B, Senn S, et al. for the UPLIFT investigators. A four year trial of tiotropium in patients with chronic obstructive pulmonary disease. New Engl J Med. 2008;359(15):1543-1554.
25. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. New Eng J Med. 2011;365(13): 1184-1192.
26. Shah PL, Slebos D-J, Cardoso PFG, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicenter trial. Lancet. 2011;378(9795): 997-1005.
27. Hopkinson NS, Kemp SV, Toma TP, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011;37(6):1346-1351.